NCT00019188View on ClinicalTrials.gov

Interleukin-12 in Treating Patients With AIDS-Related Kaposi's Sarcoma

PHASE1/PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

January 31, 1997

Study Completion Date

March 31, 2007

Conditions
Epidemic Kaposi's SarcomaRecurrent Kaposi's Sarcoma
Interventions
DRUG

interleukin-12

Trial Locations (1)

20892

Medicine Branch, Bethesda

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00019188 - Interleukin-12 in Treating Patients With AIDS-Related Kaposi's Sarcoma | Biotech Hunter | Biotech Hunter